Cargando…

Cryoglobulinemia and double‐filtration plasmapheresis: Personal experience and literature review

BACKGROUND: Cryoglobulinemia is defined as the presence of an abnormal immunoglobulin that may be responsible for vasculitis of small‐caliber vessels. Apheresis can be used in order to temporarily eliminate circulating cryoglobulins. The aim of this study was to assess the effectiveness of apheresis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naciri Bennani, Hamza, Banza, Augustin Twite, Terrec, Florian, Noble, Johan, Jouve, Thomas, Motte, Lionel, Malvezzi, Paolo, Rostaing, Lionel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084379/ https://www.ncbi.nlm.nih.gov/pubmed/35583180 http://dx.doi.org/10.1111/1744-9987.13885

Ejemplares similares

Kidney Transplantation for Focal Segmental Glomerulosclerosis: Can We Prevent Its Recurrence? Personal Experience and Literature Review
por: Naciri Bennani, Hamza, et al.
Publicado: (2021)

Belatacept Use after Kidney Transplantation and Its Effects on Risk of Infection and COVID-19 Vaccine Response
por: Terrec, Florian, et al.
Publicado: (2021)

Efficacy of Plasmapheresis in Nivolumab-Associated ANCA Glomerulonephritis: A Case Report and Pathophysiology Discussion
por: Laamech, Reda, et al.
Publicado: (2021)

Protocol Biopsies on de novo Renal-Transplants at 3 Months after Surgery: Impact on 5-Year Transplant Survival
por: Terrec, Florian, et al.
Publicado: (2021)

Late Conversion From Calcineurin Inhibitors to Belatacept in Kidney-Transplant Recipients Has a Significant Beneficial Impact on Glycemic Parameters
por: Terrec, Florian, et al.
Publicado: (2019)

Apheresis Therapy for Steroid-Resistant Idiopathic Nephrotic Syndrome: Report on a Case Series
por: Naciri Bennani, Hamza, et al.
Publicado: (2019)

Early Blood Transfusion After Kidney Transplantation Does Not Lead to dnDSA Development: The BloodIm Study
por: Jouve, Thomas, et al.
Publicado: (2022)

Very Early Severe Posttransplant Recurrent Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis after Kidney Transplantation: Two Case Reports
por: Laamech, Reda, et al.
Publicado: (2022)

Apheresis Efficacy and Tolerance in the Setting of HLA-Incompatible Kidney Transplantation
por: Noble, Johan, et al.
Publicado: (2021)

Marginal Impact of Tocilizumab Monotherapy on Anti-HLA Alloantibodies in Highly Sensitized Kidney Transplant Candidates
por: Daligault, Mélanie, et al.
Publicado: (2021)

Tocilizumab Evaluation in HLA-Desensitization before Kidney Transplantation as an Add-On Therapy to Apheresis: The TETRA Study
por: Jouve, Thomas, et al.
Publicado: (2023)

Tocilizumab and Desensitization in Kidney Transplant Candidates: Personal Experience and Literature Review
por: Weinhard, Jules, et al.
Publicado: (2021)

Transplantation of Marginal Organs: Immunological Aspects and Therapeutic Perspectives in Kidney Transplantation
por: Noble, Johan, et al.
Publicado: (2020)

Immortal Time-Bias–Corrected Survival of Highly Sensitized Patients and HLA-desensitized Kidney Transplant Recipients
por: Noble, Johan, et al.
Publicado: (2021)

Place of mTOR inhibitors in management of BKV infection after kidney transplantation
por: Jouve, Thomas, et al.
Publicado: (2016)

Induction by anti-thymocyte globulins in kidney transplantation: a review of the literature and current usage
por: Malvezzi, Paolo, et al.
Publicado: (2015)

Costimulation Blockade in Kidney Transplantation: An Update
por: Malvezzi, Paolo, et al.
Publicado: (2016)

Negative Impact of CMV and BKV Infections on Kidney-Allograft Function at 1-Year Post-Transplantation: Can it Be Changed by Modifying Immunosuppression?
por: Malvezzi, Paolo, et al.
Publicado: (2018)

Tocilizumab and Active Antibody-Mediated Rejection in Kidney Transplantation: A Literature Review
por: Cabezas, Lara, et al.
Publicado: (2022)

Tocilizumab Trough Levels Variability in Kidney-Transplant Candidates Undergoing Desensitization
por: Truffot, Aurélie, et al.
Publicado: (2021)

Tocilizumab in the Treatment of Chronic Antibody-Mediated Rejection Post Kidney Transplantation: Clinical and Histological Monitoring
por: Noble, Johan, et al.
Publicado: (2021)

A Case of Pneumocystis jirovecii Pneumonia under Belatacept and Everolimus: Benefit-Risk Balance between Renal Allograft Function and Infection
por: Perrier, Quentin, et al.
Publicado: (2021)

Double filtration plasmapheresis in a dog with multiple myeloma and hyperviscosity syndrome
por: Lippi, I., et al.
Publicado: (2015)

Double filtration plasmapheresis in the treatment of hyperproteinemia in dogs affected by Leishmania infantum
por: Perondi, Francesca, et al.
Publicado: (2018)

THERAPEUTIC PLASMA EXCHANGE AND DOUBLE FILTRATION PLASMAPHERESIS IN SEVERE NEUROIMMUNE DISORDERS
por: Roman-Filip, Corina, et al.
Publicado: (2019)

Segmental citrate anticoagulation for double-filtration plasmapheresis: A case report and literature review
por: He, Jin, et al.
Publicado: (2022)

Early post-transplant complications following ABO-incompatible kidney transplantation
por: Naciri Bennani, Hamza, et al.
Publicado: (2016)

Comparison of double filtration plasmapheresis with immunoadsorption therapy in patients with anti-glomerular basement membrane nephritis
por: Zhang, Yi-yan, et al.
Publicado: (2014)

A Study of the Immunoloregulation of Double Filtration Plasmapheresis in Maintenance Hemodialysis Patients with Chronic Hepatitis C
por: Cao, Hongdi, et al.
Publicado: (2013)

Double filtration plasmapheresis in treatment of acute pancreatitis associated with severe hypertriglyceridemia: Three case reports
por: Huang, Shih-Ping, et al.
Publicado: (2018)

Changes in Water Properties in Human Tissue after Double Filtration Plasmapheresis—A Case Study
por: Scholkmann, Felix, et al.
Publicado: (2022)

Steroid-Based Therapy and Risk of Infectious Complications
por: Rostaing, Lionel, et al.
Publicado: (2016)

Early Exposure of Kidney Transplant Recipients with Chronic Antibody-Mediated Rejection to Tocilizumab—A Preliminary Study
por: Arrivé, Capucine, et al.
Publicado: (2023)

Efficacy and safety of double-filtration plasmapheresis treatment of myasthenia gravis: A systematic review and meta-analysis
por: Liu, Chaoying, et al.
Publicado: (2021)

Double filtration plasmapheresis for pregnancy with hyperlipidemia in glycogen storage disease type Ia: A case report
por: Wang, Jie, et al.
Publicado: (2022)

Case report: Double filtration plasmapheresis (DFPP) for severe rhesus-D alloimmunization in two pregnant patients
por: Liang, Yuling, et al.
Publicado: (2023)

Double Filtration Plasmapheresis with Polyvinyl Alcohol-Based Membrane Lowers Serum Inflammation and Toxins in Patients with Hyperlipidemia
por: Liu, Wen-Sheng, et al.
Publicado: (2023)

Opportunistic Infections and Efficacy Following Conversion to Belatacept-Based Therapy after Kidney Transplantation: A French Multicenter Cohort
por: Bertrand, Dominique, et al.
Publicado: (2020)

Conversion to mTOR-Inhibitors Plus IV Immunoglobulins in Kidney-Transplant Recipients with BKV Infection: A Retrospective Comparative Study
por: Vela, Carla, et al.
Publicado: (2022)

Effect of Double Filtration Plasmapheresis on Various Plasma Components and Patient Safety: A Prospective Observational Cohort Study
por: Jagdish, K., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_k270hmjd86hek1j630tfgivlfc